Richard G. Ghalie
2021
In 2021, Richard G. Ghalie earned a total compensation of $1.1M as Chief Medical Officer at MEI Pharma.
Compensation breakdown
Non-Equity Incentive Plan | $118,065 |
---|---|
Option Awards | $522,750 |
Salary | $432,481 |
Stock Awards | $69,800 |
Total | $1,143,096 |
Ghalie received $522.8K in option awards, accounting for 46% of the total pay in 2021.
Ghalie also received $118.1K in non-equity incentive plan, $432.5K in salary and $69.8K in stock awards.
Rankings
In 2021, Richard G. Ghalie's compensation ranked 8,319th out of 12,415 executives tracked by ExecPay. In other words, Ghalie earned more than 33.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,319 out of 12,415 | 33rd |
Division Manufacturing | 3,681 out of 5,508 | 33rd |
Major group Chemicals And Allied Products | 1,635 out of 2,378 | 31st |
Industry group Drugs | 1,454 out of 2,099 | 31st |
Industry Pharmaceutical Preparations | 1,082 out of 1,549 | 30th |
Source: SEC filing on October 28, 2021.
Ghalie's colleagues
We found four more compensation records of executives who worked with Richard G. Ghalie at MEI Pharma in 2021.